In the current context of real preoccupation for identifying and implementing the most efficient measures to prevent the spreading of the A/H1N1 flu virus, GSK submits to your attention the most recent data regarding the pandemic status, efficient preventions methods and antiviral medication.

For details, please see the attached letter.